Gap analysis of pediatric reference intervals related to thyroid hormones and the growth hormone-insulin growth

Edgard E Delvin1, Vijay Laxmi Grey, Zulfikarali Vergee

  • 1Department of Clinical Biochemistry, CHU Sainte-Justine, Université de Montréal, 3175 Côte Ste-Catherine, Montréal, Québec, Canada H3T 1C5. Edgard_Delvin@ssss.gouv.qc.ca

Clinical Biochemistry
|June 10, 2006
PubMed

Insights

Pediatric reference values are crucial for accurate diagnosis and monitoring during growth and development. The Canadian Laboratory Initiative in Paediatric Reference (CALIPER) aims to establish reliable pediatric reference ranges.

Area of Science:

  • Clinical Biochemistry
  • Pediatric Laboratory Medicine

Background:

  • Reliable reference values are essential for accurate laboratory medicine diagnostics and monitoring.
  • Pediatric physiology undergoes rapid changes during growth and development, necessitating age-specific reference ranges.
  • Existing reference ranges are often lacking for critical pediatric stages like neonatal and pubertal periods.

Purpose of the Study:

  • To address the critical need for updated and comprehensive pediatric reference values.
  • To establish a pan-Canadian set of reference values for individuals from birth to late adolescence.
  • To highlight the impact of technological advancements on the necessity of redefining reference values.

Main Methods:

  • The Canadian Laboratory Initiative in Paediatric Reference (CALIPER) was established by clinical and medical biochemists.
  • The initiative aims to define a standardized set of reference values across Canada.
  • A gap analysis of biochemical variables related to thyroid function and the growth hormone-insulin-like growth factors axis was conducted.

Main Results:

  • The study highlights significant gaps in current pediatric reference ranges, particularly for neonatal and pubertal stages.
  • Technological advancements in analytical and reagent levels necessitate the redefinition of existing reference values.
  • The CALIPER initiative provides a framework for generating new, reliable pediatric reference data.

Conclusions:

  • Accurate pediatric reference values are vital for effective clinical decision-making in pediatrics.
  • The CALIPER initiative is crucial for providing updated, reliable reference ranges for Canadian children and adolescents.
  • Redefining reference values is imperative due to evolving laboratory technologies and physiological changes during development.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...